Discovery and Developmental Therapeutics

Members of the Discovery and Developmental Therapeutics program aim to translate the most promising discoveries into impactful clinical trials.

William Drobyski, MD

Program Leader

William Drobyski, MD

Professor of Medicine, Pediatrics, Microbiology & Immunology; MCW Eminent Scholar

View William Drobyski, MD Bio

Program Aims

  • Identify immunotherapeutic-based approaches for the treatment of cancer and develop strategies to suppress unwanted off-target effects
  • Employ novel imaging and radiotherapy strategies to optimize treatment of cancer and minimize therapeutic toxicity
  • Discover novel therapeutic targets that drive cancer initiation and progression

Areas of Expertise

The Discovery and Development Therapeutics program identifies immunotherapeutic approaches for cancer treatment and suppression of off-target effects; pursues novel patient-specific therapeutic targets; employs imaging and radiotherapeutic strategies to optimize cancer treatment and minimize toxicity.
  • Immuno-oncology (in-house development of CAR T-cell therapies)
  • Precision oncology and rare cancers
  • Hematologic malignancies (including genetic and epigenetic aspects of leukemia)
  • Biomedical imaging

Notable Science